The Journal of Parkinson’s Disease is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidisciplinary and aims to promote progress in the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pharmacology, psychology, diagnosis and treatment of Parkinson’s disease. It will publish research reports, reviews, short communications, and letters-to-the-editor and offers very rapid publication and an affordable open access option.
The nose or the gut? For the past two decades, the scientific community has debated the wellspring of the toxic proteins at the source of Parkinson's disease. In 2003, a German pathologist, Heiko Braak, MD, first proposed ...
Apr 11, 2024
0
51
About three years before he retired, David Campbell noticed something weird happening as he typed. Whenever he tried to hit a letter, say "a," he'd get "aaa," like the keyboard was jamming or his finger was triple-tapping ...
Jan 7, 2024
0
3
While the European Union has just renewed the approval of the use of herbicide glyphosate for another 10 years, scientists issue a call to action to reduce or replace the use of agrochemicals. Pesticides have a long-recognized ...
Dec 7, 2023
0
1
With 10 million people living with Parkinson's worldwide, collaboration and data sharing are crucial for driving innovation in drug development for the fastest-growing degenerative neurological condition.
Jul 6, 2023
0
1
When Marina Noordegraaf was diagnosed with Parkinson's disease at age 49, she noticed when it came to treatment decisions, she sometimes felt powerless. She observed that she herself played an active role in communicating ...
Mar 23, 2023
0
2
A cancer-causing chemical that is widely used to degrease aviation components and heavy machinery could also be linked to Parkinson's disease, according to a new research paper that recommends increased scrutiny of areas ...
Mar 19, 2023
2
35
A common and widely used chemical may be fueling the rise of the world's fastest growing brain condition—Parkinson's disease. For the past 100 years, trichloroethylene (TCE) has been used to decaffeinate coffee, degrease ...
Mar 14, 2023
0
159
Although there is a growing trend to involve patients in clinical research, specific guiding principles for engaging individuals with Parkinson's disease have not been established. The authors of this Call to Action published ...
May 11, 2022
0
2
The diagnosis of Parkinson's disease (PD) is currently based on consensus clinical criteria. A novel study reported in the Journal of Parkinson's Disease has found that the presence of neuronal deposits of the biomarker phosphorylated ...
Mar 15, 2022
0
41
Traditional, in-person clinical research studies have long been plagued by slow and often unsuccessful recruitment. The limits of site location, which sometimes requires participants to travel long distances, and the reliance ...
Jan 11, 2022
0
4
